290
Views
18
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant

, , , , , , , , , & show all
Pages 663-670 | Received 04 Feb 2014, Accepted 29 May 2014, Published online: 06 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Basem M. William & Marcos de Lima. (2015) Sirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better?. Leukemia & Lymphoma 56:3, pages 555-556.
Read now

Articles from other publishers (17)

Karthik Nath, Kristen Peterson, Samantha Brown, Sean Devlin, Natasia Rodriguez, Juliet Barker, Sergio Giralt, Boglarka Gyurkocza, Ann Jakubowski, Esperanza Papadopoulos, Doris Ponce, Michael Scordo, Gunjan Shah, Miguel-Angel Perales, Craig Sauter, Andrew Lin & Parastoo B. Dahi. (2023) Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy.
Crossref
Miriam Sanchez-Escamilla, Jessica Flynn, Sean Devlin, Molly Maloy, Samira A. Fatmi, Ana Alarcon Tomas, Silvia Escribano-Serrat, Doris Ponce, Craig S. Sauter, Sergio A. Giralt, Michael Scordo & Miguel-Angel Perales. (2023) EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation 58:5, pages 498-505.
Crossref
Marco Ruiz, Jannelle Vicens, Tiba Al Sagheer & Guenther Koehne. (2023) Allogeneic hematopoietic stem cell transplant for HIV patient's plasmablastic lymphoma: Case report. Current Problems in Cancer: Case Reports 9, pages 100223.
Crossref
Yiqi Su, Anat Stern, Eleni Karantoni, Tamara Nawar, Gyuri Han, Phaedon Zavras, Henry Dumke, Christina Cho, Roni Tamari, Brian Shaffer, Sergio Giralt, Ann Jakubowski, Miguel Angel Perales & Genovefa Papanicolaou. (2022) Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study. Clinical Infectious Diseases 75:5, pages 795-804.
Crossref
Irina Kostareva, Kirill Kirgizov, Elena Machneva, Nadezhda Ustyuzhanina, Nikolay Nifantiev, Yulia Skvortsova, Irina Shubina, Vera Reshetnikova, Timur Valiev, Svetlana Varfolomeeva & Mikhail Kiselevskiy. (2022) Novel and Promising Strategies for Therapy of Post-Transplant Chronic GVHD. Pharmaceuticals 15:9, pages 1100.
Crossref
Natasia Rodriguez, Jasme Lee, Lisa Flynn, Fiona Murray, Sean M. Devlin, Cristina Soto, Christina Cho, Parastoo Dahi, Sergio Giralt, Miguel-Angel Perales, Craig Sauter & Doris M. Ponce. (2021) Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy 27:11, pages 920.e1-920.e9.
Crossref
Yael Bogler, Anat Stern, Yiqi Su, Yeon Joo Lee, Susan K Seo, Brian Shaffer, Miguel-Angel Perales, Genovefa A Papanicolaou & Dionysios Neofytos. (2021) Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients. Medical Mycology 59:10, pages 970-979.
Crossref
Roni Tamari, Samantha Brown, Sean M. Devlin, Satyajit Kosuri, Molly A. Maloy, Doris M. Ponce, Craig Sauter, Brian Shaffer, Parastoo Dahi, James W. Young, Ann Jakubowski, Esperanza B. Papadopoulos, Hugo Castro-Malaspina, Miguel-Angel Perales, Sergio A. Giralt & Boglarka Gyurkocza. (2021) Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients. Transplantation and Cellular Therapy 27:10, pages 852.e1-852.e9.
Crossref
Jiaqi Fang, Yiqi Su, Phaedon D. Zavras, Amit D. Raval, Yuexin Tang, Miguel-Angel Perales, Sergio Giralt, Anat Stern & Genovefa A. Papanicolaou. (2020) Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 26:10, pages 1937-1947.
Crossref
Phaedon Zavras, Yiqi Su, Jiaqi Fang, Anat Stern, Nitasha Gupta, Yuexin Tang, Amit Raval, Sergio Giralt, Miguel Angel Perales, Ann A. Jakubowski & Genovefa A. Papanicolaou. (2020) Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study. Biology of Blood and Marrow Transplantation 26:8, pages 1482-1491.
Crossref
Djamilia Dierov, Nicholas Webb, Samira Fatmi, Chamberlain Nwanne, Cristi Ciolino, Kara Mosesso, Jimmy Nieves, Miguel‐Angel Perales, Susan E. Prockop & Doris M. Ponce. (2019) Establishing a standardized system for review and adjudication of chronic graft‐vs‐host disease data in accordance with the National Institutes Consensus criteria. ADVANCES IN CELL AND GENE THERAPY 2:4.
Crossref
Tamila L. Kindwall-Keller & Karen K. Ballen. (2017) Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!. The Oncologist 22:9, pages 1125-1134.
Crossref
Mathias Lutz & Stephan Mielke. (2016) New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease. British Journal of Clinical Pharmacology 82:5, pages 1171-1179.
Crossref
R Parody, L López-Corral, O Lopez-Godino, C Martinez, R Martino, C Solano, P Barba, D Caballero, I García-Cadenas, J L Piñana, F J Marquez-Malaver, L Vazquez, A Esquirol, J C H Boluda, F Sanchez-Guijo & J A Pérez-Simon. (2016) GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study. Bone Marrow Transplantation 51:11, pages 1524-1526.
Crossref
Philippe Armand, Haesook T. Kim, Marie-Michele Sainvil, Paulina B. Lange, Angela A. Giardino, Veronika Bachanova, Steven M. Devine, Edmund K. Waller, Neera Jagirdar, Alex F. Herrera, Corey Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Steven L. McAfee, Robert J. Soiffer, Yi-Bin Chen & Joseph H. Antin. (2016) The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial. British Journal of Haematology 173:1, pages 96-104.
Crossref
A Mussetti, S M Devlin, H R Castro-Malaspina, J N Barker, S A Giralt, A D Zelenetz, C S Sauter & M-A Perales. (2015) Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era. Bone Marrow Transplantation 50:10, pages 1293-1298.
Crossref
I Ceberio, K Dai, S M Devlin, J N Barker, H Castro-Malaspina, J D Goldberg, S Giralt, N G Adel & M-A Perales. (2015) Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT. Bone Marrow Transplantation 50:3, pages 438-443.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.